Henry Nguyen, PHARMD - Pharmacist in Bedford, NH

Henry Nguyen, PHARMD is a Pharmacist based in Bedford, New Hampshire. Henry Nguyen is licensed to practice in New Hampshire (license number 3588) and his current practice location is 1 S River Rd, Bedford, New Hampshire. He can be reached at his office (for appointments etc.) via phone at (603) 644-1275.

NPI number for Henry Nguyen is 1902210511 and his current mailing address is 1 S River Rd, Bedford, New Hampshire. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1902210511.

Contact Information

Henry Nguyen, PHARMD
1 S River Rd,
Bedford, NH 03110-6712
(603) 644-1275
(603) 644-1182

Healthcare Provider's Profile

Full NameHenry Nguyen
GenderMale
SpecialityPharmacist
Location1 S River Rd, Bedford, New Hampshire
Accepts Medicare AssignmentsDoes not participate in Medicare Program. He may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1902210511
  • Provider Enumeration Date: 06/12/2014
  • Last Update Date: 08/27/2014

Medical Identifiers

Medical identifiers for Henry Nguyen such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1902210511NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
183500000XPharmacist 3588 (New Hampshire)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Henry Nguyen is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Henry Nguyen, PHARMD
1 S River Rd,
Bedford, NH 03110-6712

Ph: () -
Henry Nguyen, PHARMD
1 S River Rd,
Bedford, NH 03110-6712

Ph: (603) 644-1275

News Archive

GlaxoSmithKline and XenoPort submit NDA for Solzira for restless legs syndrome

GlaxoSmithKline and XenoPort, Inc. announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) requesting approval of Solzira (gabapentin enacarbil) Extended Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).

Boston Scientific launches Innova Self-Expanding Bare-Metal Stent System in Europe

Boston Scientific Corporation announces CE Mark and European market launch of the Innova Self-Expanding Bare-Metal Stent System, which is designed to treat peripheral vascular lesions in arteries above the knee, specifically the superficial femoral artery (SFA) and proximal popliteal artery (PPA). The company plans to launch the product immediately in Europe and other CE Mark countries.

Boston Scientific to launch Mustang PTA Balloon Catheter worldwide

Boston Scientific Corporation today announced the global launch of its Mustangâ„¢ PTA Balloon Catheter, a highly deliverable 0.035 inch percutaneous transluminal angioplasty (PTA) catheter designed for a wide range of peripheral angioplasty procedures. The Company plans to launch the product immediately in the U.S., Europe and other international markets.

North Carolina GlaxoSmithKline Foundation awards $25,000 grants to 9 nonprofits

The North Carolina GlaxoSmithKline Foundation announced that it has awarded $25,000 grants to nine nonprofits this year, around the state to support activities that establish or expand programs that further science, education and health in local communities.

Popular Science magazine names University of Minnesota chemist among ‘Brilliant 10'

University of Minnesota chemist Christy Haynes has been named one of Popular Science magazine's "Brilliant 10," an honor that recognizes an elite group of young scientists whose research is expected to dramatically impact their fields. Haynes' profile was published today on the PopSci website and is featured in the Popular Science magazine now on newsstands.

Read more News

› Verified 5 days ago


Pharmacist in Bedford, NH

Dr. Falon Anne Kaspszak, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 209 Route 101, Bedford, NH 03110
Phone: 603-472-3919    Fax: 603-472-7448
Kim Ahearn, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 209 Route 101, Bedford, NH 03110
Phone: 603-472-3919    Fax: 603-472-7448
Laurie Keith, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 258 Wallace Rd, Bedford, NH 03110
Phone: 603-472-5847    
Nicholas Driscoll,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 258 Wallace Rd, Bedford, NH 03110
Phone: 603-472-5847    
Mrs. Ronda Lee Hatin, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 5 Colby Ct, Bedford, NH 03110
Phone: 603-622-2320    
Mrs. Lori Ellen Connors, PHARM D
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 220 S River Rd, Bedford, NH 03110
Phone: 603-263-0062    
Ms. Narmin Pirmohamed, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 8 Technology Dr, Bedford, NH 03110
Phone: 603-626-6200    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.